Search Results Search Sort by RelevanceMost Recent In the Literature Aug 2004 Ethical Issues in the Application and Prescription of CNS Interventions Abraham P. Schwab, PhD A neuroscientist and a sociologist discuss the ethical concerns with common neurological medicines that are used to enhance or change behavior. Virtual Mentor. 2004;6(8):347-349. doi: 10.1001/virtualmentor.2004.6.8.jdsc1-0408. Medicine and Society Sep 2005 The Ethics of Face Transplantation Molly Mark Major medical and ethical problems remain to be resolved before face transplantation surgery is attempted with human patients. Virtual Mentor. 2005;7(9):625-627. doi: 10.1001/virtualmentor.2005.7.9.msoc3-0509. Viewpoint Nov 2005 Steroid Hysteria: Unpacking the Claims Norman Fost, MD, MPH A physician argues in favor of the use of performance-enhancing substances by adult participants in sports. Virtual Mentor. 2005;7(11):767-769. doi: 10.1001/virtualmentor.2005.7.11.oped2-0511. In the Literature Jul 2004 Practice Makes Perfect? Ideal Standards and Practice Norms in Sports Medicine Shane K. Green, PhD A recent journal article discussed the ethical challenges faced by physicians for sports teams. Virtual Mentor. 2004;6(7):308-311. doi: 10.1001/virtualmentor.2004.6.7.jdsc1-0407. State of the Art and Science Jul 2004 Diagnosing Anabolic Steroid Use Audiey C. Kao, MD, PhD Physicians should look for specific clinical evidence when examining a patient suspected of anabolic steroid use. Virtual Mentor. 2004;6(7):316-317. doi: 10.1001/virtualmentor.2004.6.7.cprl1-0407 Case and Commentary Oct 2004 Palliative Surgery David P. Jaques, MD and Murray F. Brennan, MD Physicians must express compassion when discussing risk and success rates of palliative surgery. Virtual Mentor. 2004;6(10):440-439. doi: 10.1001/virtualmentor.2004.6.10.ccas3-0410. Medicine and Society Jul 2024 What Would Equitable Harm Reduction Look Like? Oluwole Jegede, MD, MPH, Julio C. Nunes, MD, Terence Tumenta, MD, MPH, Carmen Black, MD, and Joao P. DeAquino, MD Structural determinants of health frameworks must be person centered and express antiracism to be effective. AMA J Ethics. 2024;26(7):E572-579. doi: 10.1001/amajethics.2024.572. Medicine and Society Jul 2024 How Should Harm Reduction Be Included in Care Continua for Patients With Opioid Use Disorder? Elizabeth Salisbury-Afshar, MD, MPH, Catherine J. Livingston, MD, MPH, and Ricky N. Bluthenthal, PhD Equity requires full access to evidence-based OUD care, housing stability, and education and employment opportunities. AMA J Ethics. 2024;26(7):E562-571. doi: 10.1001/amajethics.2024.562. History of Medicine Jul 2024 Drawing on Black and Queer Communities’ Harm Reduction Histories to Improve Overdose Prevention Strategies and Policies Sterling Johnson, JD, MA and Kimberly L. Sue, MD, PhD Black and queer community-based harm reduction practices can help guide development and implementation of anti-overdose interventions. AMA J Ethics. 2024;26(7):E580-586. doi: 10.1001/amajethics.2024.580. Podcast Jul 2024 Author Interview: "Drawing on Black and Queer Communities’ Harm Reduction Histories to Improve Overdose Prevention Strategies and Policies” Sterling Johnson joins Ethics Talk to discuss his article, coauthored with Dr Kimberly L. Sue: "Drawing on Black and Queer Communities’ Harm Reduction Histories to Improve Overdose Prevention Strategies and Policies.” Pagination First page « First Previous page ‹ Previous … Page 18 Page 19 Page 20 Page 21 Page 22 Page 23 Current page 24 Page 25 Page 26 Next page Next › Last page Last »
In the Literature Aug 2004 Ethical Issues in the Application and Prescription of CNS Interventions Abraham P. Schwab, PhD A neuroscientist and a sociologist discuss the ethical concerns with common neurological medicines that are used to enhance or change behavior. Virtual Mentor. 2004;6(8):347-349. doi: 10.1001/virtualmentor.2004.6.8.jdsc1-0408.
Medicine and Society Sep 2005 The Ethics of Face Transplantation Molly Mark Major medical and ethical problems remain to be resolved before face transplantation surgery is attempted with human patients. Virtual Mentor. 2005;7(9):625-627. doi: 10.1001/virtualmentor.2005.7.9.msoc3-0509.
Viewpoint Nov 2005 Steroid Hysteria: Unpacking the Claims Norman Fost, MD, MPH A physician argues in favor of the use of performance-enhancing substances by adult participants in sports. Virtual Mentor. 2005;7(11):767-769. doi: 10.1001/virtualmentor.2005.7.11.oped2-0511.
In the Literature Jul 2004 Practice Makes Perfect? Ideal Standards and Practice Norms in Sports Medicine Shane K. Green, PhD A recent journal article discussed the ethical challenges faced by physicians for sports teams. Virtual Mentor. 2004;6(7):308-311. doi: 10.1001/virtualmentor.2004.6.7.jdsc1-0407.
State of the Art and Science Jul 2004 Diagnosing Anabolic Steroid Use Audiey C. Kao, MD, PhD Physicians should look for specific clinical evidence when examining a patient suspected of anabolic steroid use. Virtual Mentor. 2004;6(7):316-317. doi: 10.1001/virtualmentor.2004.6.7.cprl1-0407
Case and Commentary Oct 2004 Palliative Surgery David P. Jaques, MD and Murray F. Brennan, MD Physicians must express compassion when discussing risk and success rates of palliative surgery. Virtual Mentor. 2004;6(10):440-439. doi: 10.1001/virtualmentor.2004.6.10.ccas3-0410.
Medicine and Society Jul 2024 What Would Equitable Harm Reduction Look Like? Oluwole Jegede, MD, MPH, Julio C. Nunes, MD, Terence Tumenta, MD, MPH, Carmen Black, MD, and Joao P. DeAquino, MD Structural determinants of health frameworks must be person centered and express antiracism to be effective. AMA J Ethics. 2024;26(7):E572-579. doi: 10.1001/amajethics.2024.572.
Medicine and Society Jul 2024 How Should Harm Reduction Be Included in Care Continua for Patients With Opioid Use Disorder? Elizabeth Salisbury-Afshar, MD, MPH, Catherine J. Livingston, MD, MPH, and Ricky N. Bluthenthal, PhD Equity requires full access to evidence-based OUD care, housing stability, and education and employment opportunities. AMA J Ethics. 2024;26(7):E562-571. doi: 10.1001/amajethics.2024.562.
History of Medicine Jul 2024 Drawing on Black and Queer Communities’ Harm Reduction Histories to Improve Overdose Prevention Strategies and Policies Sterling Johnson, JD, MA and Kimberly L. Sue, MD, PhD Black and queer community-based harm reduction practices can help guide development and implementation of anti-overdose interventions. AMA J Ethics. 2024;26(7):E580-586. doi: 10.1001/amajethics.2024.580.
Podcast Jul 2024 Author Interview: "Drawing on Black and Queer Communities’ Harm Reduction Histories to Improve Overdose Prevention Strategies and Policies” Sterling Johnson joins Ethics Talk to discuss his article, coauthored with Dr Kimberly L. Sue: "Drawing on Black and Queer Communities’ Harm Reduction Histories to Improve Overdose Prevention Strategies and Policies.”